FOS and breast cancer: In the MCF-7 cell line, Luteolin 8-C-β-fucopyranoside, the C-glycoside of Luteolin without O-glycoside, was also reported to suppress the invasion of breast cancer cells by ERK1/activator protein-1 (AP-1) and ERK/NF-κB pathways [126].